Le Lézard
Classified in: Health
Subject: NEW PRODUCTS/SERVICES

CloudMD Launches Kii Personalized & Connected Care, the New Brand Identity for its Transformational Integrated Health Services Offering


VANCOUVER, British Columbia, May 26, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) ("CloudMD" or the "Company"), a healthcare technology and innovative health services company transforming the delivery of care, is excited to announce the launch of Kii Personalized & Connected Care by CloudMD, the new brand identity for its integrated, health services offering. Kii, is the company's flagship offering which integrates several of its best-in-class technologies and services into one exceptional, connected, and personalized experience for employees that will continue to disrupt the traditional employer healthcare industry. Kii is focused on personalizing care by taking a whole-person approach with an emphasis on continuity of care across mental, physical and workplace safety.

Over the last 6 months, the CloudMD team has been working to develop the new Kii brand identity and positioning for its integrated platform, which has already seen successful adoption in the marketplace. The new Kii brand reflects a brand purpose of empowering individuals to take control of their health and plays off the word "key" ie. "Holding the key to your health". The essence of the brand is meant to embody caring, the whole body, trust, and connectivity. The Kii brand promise is to provide connected care, which is the key enabler to an individual's health and wellbeing and ability to thrive.

Karen Adams, Interim CEO and President of CloudMD commented, "We are thrilled to launch Kii, a transformation program that enables access to personalized care for mental and physical health issues across an individual's life journey. Kii brings together what we have known as transactional service approaches that lead to disconnected and fragmented experiences. With the connected and outcome focused approach of Kii, the program drives accountability for behaviour change resulting in better return on investment and clinical health outcomes. Kii addresses the barriers to care by efficiently supporting access through multiple modalities designed to meet the individual's specific needs. Kii supports individuals who require mental and physical health treatment plans but also demonstrates strong, positive return to work outcomes for people experience absence support or disability services."  

Karen Adams continued, "We intend to build long standing relationships with the individuals and will continuously support and encourage them to actively engage in their treatment. We believe Kii is the solution that individuals and organizations will come to depend on for the full spectrum of mental and physical health needs. They can depend on CloudMD to focus on the personalized health needs of individuals resulting in better health outcomes for the individual and improved ROI for the company."

Over the past few years, thousands of individual employers and organizations have switched from transactional providers to CloudMD across its suite of services. Employers, advisors, insurers and employees have provided consistent feedback that they are frustrated with the services they receive, and face long wait times and too many barriers in accessing high-quality care. This is magnified when a user is forced into digital-only experiences without phone access or in-person options available.

Kii differentiates itself in the market through:

Kii Personalized & Connected Care Video

To learn more about Kii, please watch this short highlight video.

About CloudMD Software & Services

CloudMD is transforming the delivery of healthcare using technology and by providing a patient-centric approach, with an emphasis on continuity of care. By leveraging healthcare technology, the Company is building one, connected platform that addresses all points of a patient's healthcare journey and provides better access to care and improved outcomes. Through CloudMD's proprietary technology, the Company delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, healthcare navigation, educational resources, and artificial intelligence (AI). CloudMD's business is separated into three main divisions: Clinics and Pharmacies, Digital Solution and Enterprise Health Solutions, the Company's fastest growing division. CloudMD's Enterprise Health Solutions Division has built a leading employer healthcare solution, including its Comprehensive Integrated Health Services Platform, which offers one comprehensive, digitally connected platform for educational institutions, corporations, insurers, and advisors to better manage the health and wellness of their students, employees, and customers.

CloudMD currently services a direct ecosystem of over 5,700 clinicians including, 1,800+ mental health practitioners, 1,600+ allied health professionals, 1,400+ doctors and nurses and covers 12 million individual lives across North America. For more information visit: https://investors.cloudmd.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

"Karen Adams"
Interim Chief Executive Officer & President

FOR ADDITIONAL INFORMATION CONTACT:

Julia Becker
VP, Investor Relations
[email protected]
(604)785-0850

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

FORWARD-LOOKING STATEMENTS

This news release contains "forward-looking statements" and "forward-looking information" within the meaning of Canadian securities laws. Forward-looking statements in this news release include, but are not limited to, statements regarding the Company's plans and expectations with respect to the business; and the impact of such plans. These statements are based upon information currently available to CloudMD's management. All information that is not clearly historical in nature may constitute forward?looking statements. In some cases, forward?looking statements may be identified by the use of terms such as "forecast", "assumption" and other similar expressions or future or conditional terms such as "anticipate", "believe", "could", "estimate", "expect", "intend", "may", "plan", "predict", "project", "will", "would", and "should". Forward-looking statements contained in this news release are based on certain factors and assumptions made by management of CloudMD based on their current expectations, estimates, projections, assumptions and beliefs regarding their business and CloudMD does not provide any assurance that actual results will meet management's expectations. While management considers these assumptions to be reasonable based on information currently available to them, they may prove to be incorrect. Such forward?looking statements are not guarantees of future events or performance and by their nature involve known and unknown risks, uncertainties and other factors, including those risks described in the Company's MD&A and most recent Annual Information Form (which are filed under the Company's issuer profile on SEDAR and can be accessed at www.sedar.com), that may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward?looking statements. Although CloudMD has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward?looking statements, other factors may cause actions, events or results to be different than anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could vary or differ materially from those anticipated in such forward?looking statements. Accordingly, readers should not place undue reliance on forward?looking information. CloudMD does not undertake to update any forward-looking information, whether as a result of new information or future events or otherwise, except as may be required by applicable securities laws.

 



These press releases may also interest you

at 03:52
The progressive decrease in hearing in elderly people can represent a major problem for their quality of life: it has in fact been demonstrated that critical issues such as these, in addition to being a problem as such, can...

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...



News published on and distributed by: